Results: ERGO

Search articles by EPIC code

NEWSFLOW

Ergomed (#ERGO) – 1350p per share recommended offer from Permira with a “partial securities alternative”

2023-09-04 06:59:59

views

Cancer Trial King is Worth a Look as It Keeps on Growing in a Growing Medical World

Hello Share Swappers. Medical companies have a favourable spot in my humble musings on possible share success. Today’s choice for your further perusal is Ergomed (ERGO). This is a niche company, another reason for me to favour it.

By Malcolm Stacey
2022-08-16 08:15:53

views

ERGO Provides a High-Demand Medical Service, Ergo: its Share Price Could Rise

Hello, Share Troopers. Ergomed (ERGO) is an AIM company which does something fashionable these days. It helps makes sure that medical drugs and remedies pass the required tests to come on the market. It also monitors pharmaceutical products once they’re in circulation. It’s not just Covid vaccines that need investigation, of course. Many more drug trials are taking place all the time.

By Malcolm Stacey
2020-12-14 08:15:45

views

Ergomed receives a "buy" recommendation - You is avin a giraffe gents: sell

Ergomed (ERGO) receives a "buy" recommendation is the headline of the RNS Reach that has just gone out. It is very unusual to announce a broker report so I had a butchers at the RNS Reach - a Reach is an announcement the Nomad deems not to be price sensitive. Read on and you see why.